Inhibition of donor-derived T cells trafficking into target organs by FTY720 during acute graft-versus-host disease in small bowel transplantation

Clinical and Experimental Immunology

Volumn 146, Issue 1, 2006, Pages 85-92

  Song, J ^a   Ito, T ^a,b   Matsuda, C ^a   Miao, G ^a   Tanemura, M ^a   Nishida, T ^a   Nozawa, M ^a   Matsuda, H ^a   Sawa, Y ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Donor derived T cells; FTY720; GVHD (graft versus host disease); IFN ; Small bowel transplantation

Indexed keywords

CYTOKINE; FINGOLIMOD; SPHINGOSINE 1 PHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; GENE MUTATION; GRAFT VERSUS HOST REACTION; HETEROTOPIC TRANSPLANTATION; HISTOPATHOLOGY; INTESTINE TRANSPLANTATION; LETHALITY; LYMPHOCYTE COUNT; MALE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RAT; SURVIVAL; T LYMPHOCYTE SUBPOPULATION;

ACUTE DISEASE; ANIMALS; BODY WEIGHT; CYTOKINES; GRAFT VS HOST DISEASE; IMMUNOSUPPRESSIVE AGENTS; INTESTINE, SMALL; LIVER; LYMPHOCYTE COUNT; MALE; PROPYLENE GLYCOLS; RATS; RATS, INBRED WF; SKIN; SPHINGOSINE; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION CHIMERA;

EID: 33748694770     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03175.x     Document Type: Article

References (39)

1. Langnas AN. Advances in small-intestine transplantation. Transplantation 2004; 77:S75-8.
2. Gale RP. Graft-versus-host disease. Immunol Rev 1985; 88:193-214.
3. Mazariegos GV, Abu-Elmagd K, Jaffe R et al. Graft versus host disease in intestinal transplantation. Am J Transplant 2004; 4:1459-65.
4. Blazar BR, Taylor PA, Snover DC, Bluestone JA, Vallera DA. Nonmitogenic anti-CD3F(ab′)2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier. J Immunol 1993; 150:265-77.
5. Rus V, Svetic A, Nguyen P, Gause WC, Via CS. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells. J Immunol 1995; 155:2396-406.
6. Yanagawa Y, Sugahara K, Kataoka H, Kawaguchi T, Masubuchi Y, Chiba K. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. J Immunol 1998; 160:5493-9.
7. Hwang MW, Matsumori A, Furukawa Y et al. FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation. Circulation 1999; 100:1322-9.
8. Suzuki S, Enosawa S, Kakefuda T et al. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces longterm graft acceptance in rat and dog allotransplantation. Transplantation 1996; 61:200-5.
9. Mizushima T, Ito T, Kishi D et al. Therapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with colitis. Inflamm Bowel Dis 2004; 10:182-92.
10. Chiba K, Yanagawa Y, Masubuchi Y et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol 1998; 160:5037-44.
11. Luo ZJ, Tanaka T, Kimura F, Miyasaka M. Analysis of the mode of action of a novel immunosuppressant FTY720 in mice. Immunopharmacology 1999; 41:199-207.
12. Henning G, Ohl L, Junt T et al. CC chemokine receptor 7-dependent and -independent pathways for lymphocyte homing: modulation by FTY720. J Exp Med 2001; 194:1875-81.
13. Forster R, Schubel A, Breitfeld D et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999; 99:23-33.
14. Mandala S, Hajdu R, Bergstrom J et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002; 296:346-9.
15. Brinkmann V, Davis MD, Heise CE et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 2002; 277:21453-7.
16. Kimura T, Hasegawa T, Nakai H et al. FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells. Transplantation 2003; 75:1469-74.
17. Sakagawa T, Kiyochi H, Honda K, Kobayashi N. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation. Transpl Immunol 2004; 13:161-8.
18. Mitsusada M, Suzuki S, Kobayashi E, Enosawa S, Kakefuda T, Miyata M. Prevention of graft rejection and graft-versus-host reaction by a novel immunosuppressant, FTY720, in rat small bowel transplantation. Transpl Int 1997; 10:343-9.
19. Monchik GJ, Russell PS. Transplantation of small bowel in the rat: technical and immunological considerations. Surgery 1971; 70:693-702.
20. Kobayashi E, Kamada N, Enosawa S et al. Comparison of potentiality to induce graft-versus-host reaction with small bowel, pancreas/spleen, and liver transplantation in the rat. Clin Exp Immunol 1993; 92:527-31.
21. Davies MD, Parrott DM. Preparation and purification of lymphocytes from the epithelium and lamina propria of murine small intestine. Gut 1981; 22:481-8.
22. Takahashi I, Kiyono H, Hamada S. CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice. Gastroenterology 1997; 112:1876-86.
23. Hashimoto W, Takeda K, Anzai R et al. Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12. J Immunol 1995; 154:4333-40.
24. Pinschewer DD, Ochsenbein AF, Odermatt B, Brinkmann V, Hengartner H, Zinkernagel RM. FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J Immunol 2000; 164:5761-70.
25. Wang ME, Tejpal N, Qu X et al. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus. Transplantation 1998; 65:899-905.
26. Brinkmann V, Cyster JG, Hla T. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant 2004; 4:1019-25.
27. Shlomchik WD, Couzens MS, Tang CB et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999; 285:412-5.
28. Kataoka Y, Iwasaki T, Kuroiwa T et al. The role of donor T cells for target organ injuries in acute and chronic graft-versus-host disease. Immunology 2001; 103:310-8.
29. Kurlberg G, Lycke N, Haglind E. Migration of host and donor T cells in small bowel transplantation. Transpl Int 1997; 10:45-50.
30. Kim YM, Sachs T, Asavaroengchai W, Bronson R, Sykes M. Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720. J Clin Invest 2003; 111:659-69.
31. Szymula von Richter TP, Baumeister RG. Allograft survival prolongation after microsurgical lymphatic reconstruction in a short-term immunosuppressed rat small bowel transplantation model. Transplant Proc 1997; 29:1804-6.
32. Goott B, Lillehei C, Miller FA. Mesenteric lymphatic regeneration after autografts of small bowel in dogs. Surgery 1960; 48:571-5.
33. Kellersman R, Zhong R, Kiyochi H, Garcia B, Grant DR. Reconstruction of the intestinal lymphatic drainage after small bowel transplantation. Transplantation 2000; 69:10-6.
34. Halin C, Scimone ML, Bonasio R et al. The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches. Blood 2005; 106:1314-22.
35. Tsuji S, Char D, Bucy RP, Simonsen M, Chen CH, Cooper MD. Gamma delta T cells are secondary participants in acute graft-versus-host reactions initiated by CD4+ alpha beta T cells. Eur J Immunol 1996; 26:420-7.
36. Drobyski WR, Majewski D, Hanson G. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease. Biol Blood Marrow Transplant 1999; 5:222-30.
37. Imado T, Iwasaki T, Kuroiwa T, Sano H, Hara H. Effect of FK506 on donor T-cell functions that are responsible for graft-versus-host disease and graft-versus-leukemia effect. Transplantation 2004; 77:391-8.
38. Snider D, Liang H. Early intestinal Th1 inflammation and mucosal T cell recruitment during acute graft-versus-host reaction. J Immunol 2001; 166:5991-9.
39. Sawicka E, Zuany-Amorim C, Manlius C et al. Inhibition of Th1-and Th2-mediated airway inflammation by the sphingosine 1-phosphate receptor agonist FTY720. J Immunol 2003; 171:6206-14.